-
1.
Athavale A, et al. Desmopressin and bleeding risk after percutaneous kidney biopsy. BMC Nephrol 2019; 20:413. doi: 10.1186/s12882-019-1595-4.
-
2.
Manno C, et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66:1570–1577.
-
3.
Peters B, et al. Desmopressin (Octostim®) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: a pilot study. Nephrology (Carlton) 2018; 23:366–370.
-
4.
Lim CC, et al. Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia. Int Urol Nephrol 2019; 51:995–1004.
-
5.
Moledina DG, et al. Kidney biopsy-related complications in hospitalized patients with acute kidney disease. Clin J Am Soc Nephrol 2018; 13:1633–1640.
Desmopressin and Bleeding after Kidney Biopsy
Creatinine Level May Affect Risk
Search for other papers by Tim O’Brien in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory